We are an iconic provider of hospital-based healthcare, striving to deliver an exceptional standard of care
We comprise several hospitals, health centres, a nationally accredited education provider and a world-class research institute
We are a nationally accredited, hospital-based Registered Training Organisation - the only one of its kind in Queensland
We are part of a collaborative research institute with The University of Queensland and founding partner of the Translational Research Institute
Health . Education . Research . Foundation
Recognising the potential of precision medicine – developing treatments that were more efficacious and less toxic – led Mater Research Executive Director Professor ...
Mater Research and Mater Hospital Townsville have put skin and melanoma research under the spotlight in North Queensland, joining the World Science Festival in taking ...
Important new transformative projects between Mater Researchers and Mater Health clinicians have been given the green light.
It is estimated over 110 000 people are living with blood cancer or a related blood disorder in Australia today and sadly 15 people lose their life to blood cancer ...
During a world first therapy conducted at the Princess Alexandra Hospital by Mater Researcher and Haematologist Professor Maher Gandhi a 46-year-old patient Scott ...
Trevor Young was diagnosed with acute myeloid leukemia earlier this year and was kind enough to share his cancer journey in the hopes of raising awareness and funds ...
Today on World Lymphoma Awareness Day the staff of wards 8 East and North at Mater Private Hospital Brisbane dressed in lime to raise awareness of lymphoma symptoms ...
A drug currently in clinical trials has the potential to improve the survival rate of Australians diagnosed with acute myeloid leukaemia, preclinical research ...
Mater Research CEO Professor Maher Gandhi has been appointed to a new National Blood Cancer Taskforce to deliver Australia’s first National Strategic Action Plan for ...
Mater Research CEO and MRI-UQ Director Professor Maher Gandhi and his team report that immune-infiltration is a promising tool to improve outcomes for patients with ...
More Australians living with follicular lymphoma could benefit from tailored treatment through development of a new clinical scoring model thanks to Mater Research.
Mater Research CEO Professor Maher Gandhi has secured additional funding from the Leukaemia Foundation to investigate a new therapeutic approach for follicular ...